Rubén Morilla

Prof. Dr. Rubén Morilla

University of Seville, Seville, Spain
+2
orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 July 2007 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
Enrique CalderonEnrique Calderon
Enrique Calderon
LRLaura Rivero
Laura Rivero
NRNieves Respaldiza
Nieves Respaldiza
RMRubén Morilla
Rubén Morilla
MMMarco A. Montes-Cano
Marco A. Montes-Cano
CHCarmen de la Horra
Carmen de la Horra
In chronic obstructive pulmonary disease, high levels of airway and systemic inflammatory markers are associated with a faster decrease in lung funct

1 July 2008 in Emerging Infectious Diseases
Verified
Journal Article
Open access
LRLaura Rivero
Laura Rivero
CHCarmen de la Horra
Carmen de la Horra
MMMarco A. Montes-Cano
Marco A. Montes-Cano
ARAlfonso Rodríguez-Herrera
Alfonso Rodríguez-Herrera
NRNieves Respaldiza
Nieves Respaldiza
Enrique CalderonEnrique Calderon
Enrique Calderon
We report a case of Pneumocystis jirovecii transmission from colonized grandparents to their infant granddaughter. Genotyping of P. jirovecii showed the same genotypes in samples from the infant and her grandparents. These findings support P. jirovecii transmission from immunocompetent carrier adults to a susceptible child.

12 November 2010 in European Journal of Clinical Investigation
Verified
Journal Article
Closed access
PDF file
GWGustavo Wissmann
Gustavo Wissmann
RMRubén Morilla
Rubén Morilla
IMIsabel Martín-Garrido
Isabel Martín-Garrido
VFVicente Friaza
Vicente Friaza
NRNieves Respaldiza
Nieves Respaldiza
Enrique CalderonEnrique Calderon
Enrique Calderon

22 February 2022 in Nutrients
Verified
Journal Article
Open access
PDF file
TKTatianna Elena Oliva Kowalsky
Tatianna Elena Oliva Kowalsky
RMRubén Morilla
Rubén Morilla
Isabel Cerrillo GarcíaIsabel Cerrillo García
Isabel Cerrillo García
Background. Climate change and global health are inextricably linked. Thus, health systems and their professionals must adapt and evolve without losing quality of care. Aim(s). To identify health and environmental co-benefits derived from a sustainable diet and promotion strategies that favor its implementation. Methods. A systematic search for articles published on sustainable diets and human/planetary health published between 2013 and 2020 was conducted on the databases PubMed, Cinahl, Scopus and Trip from 4 to 7 May 2020 in accordance with the PRISMA guideline. Results. A total of 201 articles was retrieved, but only 21 were included. A calorie-balanced diet mainly based on food of plant origin that would allow the attainment of 60% of daily caloric requirements and a low protein intake from animal foods (focusing in fish and poultry) could significantly reduce global morbi-mortality and the dietary environmental impact maintaining a framework of sustainability conditioned by the consumption of fresh, seasonal, locally produced and minimally packaged products. Discussion. The implementation of sustainable diets requires working on the triangulation of concepts of food–health–environment from schools and that is permanently reinforced during all stages of the life by healthcare workers, who should establish the appropriate modifications according to the age, gender and health situation.

1 July 2012 in Medical Mycology
Verified
Journal Article
Open access
PDF file
MPMarco A. Pederiva
Marco A. Pederiva
GWGustavo Wissmann
Gustavo Wissmann
VFVicente Friaza
Vicente Friaza
RMRubén Morilla
Rubén Morilla
CHCarmen de La Horra
Carmen de La Horra
JPJoão C. Prolla
João C. Prolla
A high rate of Pneumocystis jirovecii colonization was observed in Brazilian cystic fibrosis (CF) patients (13 out of 34; 38.2%) who underwent bronch

13 October 2021 in Journal of Fungi
Verified
Journal Article
Open access
PDF file
CHCarmen de la Horra
Carmen de la Horra
VFVicente Friaza
Vicente Friaza
RMRubén Morilla
Rubén Morilla
JDJuan Delgado-Cuesta
Juan Delgado-Cuesta
FMFrancisco J Medrano
Francisco J Medrano
Enrique CalderonEnrique Calderon
Enrique Calderon
A Pneumocystis jirovecii is one of the most important microorganisms that cause pneumonia in immunosupressed individuals. The guideline for treatment and prophylaxis of Pneumocystis pneumonia (PcP) is the use of a combination of sulfa drug-containing trimethroprim and sulfamethoxazole. In the absence of a reliable method to culture Pneumocystis, molecular techniques have been developed to detect mutations in the dihydropteroate synthase gene, the target of sulfa drugs, where mutations are related to sulfa resistance in other microorganisms. The presence of dihydropteroate synthase (DHPS) mutations has been described at codon 55 and 57 and found almost around the world. In the current work, we analyzed the most common methods to identify these mutations, their geographical distribution around the world, and their clinical implications. In addition, we describe new emerging DHPS mutations. Other aspects, such as the possibility of transmitting Pneumocystis mutated organisms between susceptible patients is also described, as well as a brief summary of approaches to study these mutations in a heterologous expression system.